HomeInsightsStock Comparison

Aristo Bio Tech Lifescience Ltd vs Bharat Rasayan Ltd Stock Comparison

Aristo Bio Tech Lifescience Ltd vs Bharat Rasayan Ltd Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

  • The Latest Trading Price of Aristo Bio-Tech & Lifescience Ltd is ₹ 120 as of 30 Apr 15:30 . The P/E Ratio of Aristo Bio-Tech & Lifescience Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Bharat Rasayan Ltd changed from 24.4 on March 2021 to 31.1 on March 2025 . This represents a CAGR of 4.97% over 5 years The Market Cap of Aristo Bio-Tech & Lifescience Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Bharat Rasayan Ltd changed from ₹ 3997 crore on March 2021 to ₹ 4377 crore on March 2025 . This represents a CAGR of 1.83% over 5 years The revenue of Aristo Bio-Tech & Lifescience Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Bharat Rasayan Ltd for the Dec '25 is ₹ 287.48 crore as compare to the Sep '25 revenue of ₹ 296.73 crore. This represent the decline of -3.12% The ebitda of Aristo Bio-Tech & Lifescience Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Bharat Rasayan Ltd for the Dec '25 is ₹ 59.79 crore as compare to the Sep '25 ebitda of ₹ 43.84 crore. This represent the growth of 36.38% The net profit of Aristo Bio-Tech & Lifescience Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Bharat Rasayan Ltd changed from ₹ 43.12 crore to ₹ 40.03 crore over 7 quarters. This represents a CAGR of -4.16% The Dividend Payout of Aristo Bio-Tech & Lifescience Ltd changed from 4.78 % on March 2023 to 8.39 % on March 2025 . This represents a CAGR of 20.63% over 3 yearsThe Dividend Payout of Bharat Rasayan Ltd changed from 0.39 % on March 2021 to 0.5 % on March 2025 . This represents a CAGR of 5.09% over 5 years .

About Aristo Bio-Tech & Lifescience Ltd

  • Aristo Bio-Tech & Lifescience Limited was originally incorporated on March 17, 2005 as 'Aristo Bio-Tech and Lifescience Private Limited' with the Registrar of Companies, Maharashtra, Mumbai.
  • Subsequently Company converted into Public Limited Company and name of company was changed to 'Aristo Bio-Tech and Lifescience Limited' vide fresh Certificate of Incorporation dated May 20, 2020.
  • The Company came out with a Public Issue by allotting 18,12,800 Equity Shares of face value of Rs 10 each in January, 2023 by raising funds of Rs. 13.05 Cr. through Fresh Issue. Aristo Bio-Tech & Lifescience is an agrochemical company engaged in the manufacturing, formulation, supplying, packaging and job work services in various Pesticides such as Insecticides, Herbicides, Fungicides, Plant Growth Regulators and other Agrochemicals.

About Bharat Rasayan Ltd

  • Bharat Rasayan Limited (BRL) was incorporated as Public Limited Company on May 15, 1989 for the business of manufacturing the Pesticides.
  • The Company manufacture Technical Formulation and Intermediates.
  • Promoted by S N Gupta and Bharat Insecticides, it manufacture own technical grade pesticides, including Metaphenoxy Benzaldehyde, Fenvalerate, Cypermethrin, Ethyl Ester and Isoproturon. Bharat Rasayan Limited has a Joint Venture Agreement, with Nissan Chemical Corporation (NCC), a company incorporated in Japan, and with Nissan Bharat Rasayan Private Limited, a company incorporated in India.
  • The Company came out with a Public Issue in Feb 1993 to expand its existing capacity as well as to add manufacturing facility for another type of pesticide. The products of the company are used as raw material by pesticide formulating units whose products are essentially used for plant protection and accelerated output in the agricultural sector.

FAQs for the comparison of Aristo Bio-Tech & Lifescience Ltd and Bharat Rasayan Ltd

Which company has a larger market capitalization, Aristo Bio-Tech & Lifescience Ltd or Bharat Rasayan Ltd?

Market cap of Aristo Bio-Tech & Lifescience Ltd is 81 Cr while Market cap of Bharat Rasayan Ltd is 2,307 Cr

What are the key factors driving the stock performance of Aristo Bio-Tech & Lifescience Ltd and Bharat Rasayan Ltd?

The stock performance of Aristo Bio-Tech & Lifescience Ltd and Bharat Rasayan Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aristo Bio-Tech & Lifescience Ltd and Bharat Rasayan Ltd?

As of May 3, 2026, the Aristo Bio-Tech & Lifescience Ltd stock price is INR ₹120.0. On the other hand, Bharat Rasayan Ltd stock price is INR ₹1388.3.

How do dividend payouts of Aristo Bio-Tech & Lifescience Ltd and Bharat Rasayan Ltd compare?

To compare the dividend payouts of Aristo Bio-Tech & Lifescience Ltd and Bharat Rasayan Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions